Andere Sprachen Hikma Pharmaceuticals PLC

Aktien

A0HG69

GB00B0LCW083

HIK

Markt geschlossen - London S.E. Andere Börsenplätze 17:35:27 24.04.2024			% 5 Tage	% 1. Jan.
1.813 ^GBX	-0,33 %		+2,20 %	+1,34 %

15.04.	Hikma Pharmaceuticals PLC kündigt Änderungen in der Geschäftsführung an	CI
04.03.	Neuseeländische Aktien schließen am Montag flach; Fletcher Building Chair tritt zurück	MT

Andere Sprachen

Erhalten Sie Zugang zu allen Nachrichten über alle Unternehmen: Verpassen Sie keine profitable Anlagechance mehr!

100% kostenlose Registrierung

Hikma appoints Dr. Hafrun Fridriksdottir as President of Generics business	16.04.
Hikma Pharmaceuticals PLC Announces Executive Changes	15.04.
FTSE 100 Closes Up 0.12% Ahead of U.K. Jobs Data	11.03.
The FTSE 100 Closed Up 0.4% as U.K. Announces Spring Budget Tax Cuts	06.03.
Rakuten Medical, Inc. announced that it has received $45 million in funding from Dai-ichi Life Holdings, Inc., Mizuho Bank, Ltd., Hikma Pharmaceuticals PLC, Rakuten Ventures, SBI Holdings, Inc., Investment Arm and another investor	06.03.
New Zealand Shares Close Flat on Monday; Fletcher Building Chair Steps Down	04.03.
AFT Pharmaceuticals to Expand Global Footprint with Signing of Supply, Production Deals	04.03.
AFT Pharmaceuticals Limited Extends License for Maxigesic/Combogesic IV with Hikma Pharmaceuticals	03.03.
Barclays cuts Direct Line to equal weight	29.02.
Stocks called up following slew of FTSE 100 earnings	29.02.
Hyloris Pharmaceuticals: le Maxigesic IV commercialisé aux Etats-unis	28.02.
Hyloris Partner Hikma Launches Pain Medication in US, Obtains Approval in Canada	28.02.
Merck's Bridion faces generic threat from drugmaker Hikma	26.02.
Barclays raises Breedon but cuts Domino's Pizza	23.02.
FTSE 100 Closes Up After Nvidia Results Lead to Global Rally	22.02.
HIKMA PHARMACEUTICALS : Strong Generics-led finish to 2023	22.02.
Berenberg raises Moneysupermarket.com to 'buy'	22.02.
Hikma boosts dividend after year of "significant progress"	22.02.
Drugmaker Hikma expects profit to be slightly lower in 2024	22.02.
Hikma Pharmaceuticals Reports Improved FY23 Profit, Revenue	22.02.

Keine Ergebnisse zu dieser Suche

Alle Nachrichten Analystenempfehlungen Wichtige Fakten Insiders Transkripte Pressemitteilungen Offizielle Publikationen Andere Sprachen Trading-Ideen MarketScreener Artikel MarketScreener Analysen

Filter

Schlagzeilen

HIKMA PHARMACEUTICALS : Starker Abschluss von Generika bis 2023

Am 22. Februar 2024 um 15:22 Uhr